• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 HYPERGLIDE; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 HYPERGLIDE; CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY Back to Search Results
Model Number 104-4112
Device Problem Inflation Problem (1310)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/12/2023
Event Type  malfunction  
Manufacturer Narrative
H3: product analysis of 104-4112, lotno:b232739 found no damages or irregularities with the x-pedion guidewire pusher or guidewire tip.No damages were found with the hyperglide hub, catheter body or marker bands.The distal balloon subassembly (distal to the marker band) was found damaged with what appears to be a large hole (patch missing).There was no evidence that the balloon has been previously inflated.The hyperglide occlusion balloon catheter was flushed, and water exited the distal tip.The returned guidewire was hydrated, and then inserted into the balloon catheter.The guidewire was extended out the distal tip ~3cm to test for balloon inflation.The balloon failed to inflate as water was observed to exit the damaged location.Based on the device analysis and reported information, the customer¿s reports of ¿no/slow inflation during procedure¿ was confirmed.The cause of the failure to inflate was found to be the large hole found on the balloon subassembly.The customer did not report any inflation attempts during preparation and that the balloon failed to inflate during procedure and after removal from the patient.Therefore, the cause of the damage and failure to inflate cannot be determined.It is possible the damages occurred during preparation, during insertion into the patient, or potentially during manufacturing.As manufacturing cannot be ruled out as a potential cause, a dhr review will be performed.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received a report that for a large aneurysm of the c4 segment of the internal carotid artery, 18-20mm, the physician used the occluding balloon catheter system to assist embolization.After the occluding balloon catheter system was placed in place, the balloon could not be inflated and then withdrew from the body.It also could not be inflated outside the body.  the balloon was replaced and the surgery went smoothly.No patient symptoms or further complications were reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYPERGLIDE
Type of Device
CATHETER, INTRAVASCULAR OCCLUDING, TEMPORARY
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18502796
MDR Text Key333022616
Report Number2029214-2024-00101
Device Sequence Number1
Product Code MJN
UDI-Device Identifier00763000294359
UDI-Public00763000294359
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K101570
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number104-4112
Device Catalogue Number104-4112
Device Lot NumberB232739
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/02/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/15/2023
Date Device Manufactured07/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age50 YR
Patient SexMale
-
-